High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
City of Hope Medical Center
RemeGen Co., Ltd.
Regeneron Pharmaceuticals
University of Oklahoma
NRG Oncology
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
AstraZeneca
University Health Network, Toronto
Cullinan Therapeutics Inc.
Enliven Therapeutics
Amgen
Dana-Farber Cancer Institute
University of Pennsylvania
University of Southern California
Dana-Farber Cancer Institute
Toray Industries, Inc
Washington University School of Medicine
DEKA Biosciences